Peter Sandercock


Professor Peter Sandercock studied Medicine at the University of Oxford, and undertook postgraduate clinical training in Stoke-on-Trent, Manchester, Oxford and Liverpool, followed by a visiting academic fellowship at McMaster University Canada. His initial research was on the epidemiology of stroke in Oxfordshire, and in clinical trials of stroke prevention. Professor Sandercock set up and ran the first International Stroke Trial (IST-1), the first ‘mega-trial’ in acute ischaemic stroke from 1991-1997. He was the Co-Chief Investigator of IST-3, the largest-ever trial of ‘clot-busting’ thrombolytic therapy for acute ischaemic stroke with 3035 patients. He has a major interest in clinical trials, systematic reviews and Evidence-Based Medicine.

Conference Reports